Abstract
ObjectivesParenteral drug products should be essentially free from visible particulate contamination. To ensure this, every batch produced must be subject to a 100% visual inspection. Monograph 2.9.20 of the European...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have